Parallel Advisors’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
Other funds holding KURA
Parallel Advisors's KURA Position: Q3 2026 in Review
Parallel Advisors held its Kura Oncology (KURA) position steady in Q3 2026 at 309 shares worth $3.31K. The position accounts for ﹤0.01% of the portfolio, ranked #3506.
Parallel Advisors first reported a position in KURA in Q2 2020 and has held it in 15 quarters since. The position peaked at $4.17K in Q1 2026. 55 funds tracked by Wall St. Rank hold KURA as of Q3 2026.
- Parallel Advisors held 309 shares of Kura Oncology worth $3.31K as of Q3 2026.
- Parallel Advisors left its Kura Oncology share count unchanged in Q3 2026.
- Kura Oncology made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #3506 holding.
- Parallel Advisors first reported a position in Kura Oncology in Q2 2020 and has held it in 15 quarters since.
- Parallel Advisors's Kura Oncology position peaked at $4.17K in Q1 2026.
- 55 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.
Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.